News about "research collaboration"

Astex Partners with Genentech on Breast Cancer Therapy Research

Astex Partners with Genentech on Breast Cancer Therapy Research

Astex has entered an exclusive research and licensing agreement with Genentech for a breast cancer therapy program, with potential deal value exceeding USD 490 million plus tiered royalties.

Research Collaboration | 07/07/2026 | By News Bureau

Simcere Pharmaceutical and Stanford Medicine Partner on IPF Therapy Research

Simcere Pharmaceutical and Stanford Medicine Partner on IPF Therapy Research

Simcere Pharmaceutical has entered a research collaboration with Stanford Medicine to develop innovative therapies for Idiopathic Pulmonary Fibrosis (IPF).

Research Collaboration | 16/06/2026 | By News Bureau

Dalriada Drug Discovery, Topos Bio Partner to Advance AI-Driven Drug Discovery for Intrinsically Disordered Proteins

Dalriada Drug Discovery, Topos Bio Partner to Advance AI-Driven Drug Discovery for Intrinsically Disordered Proteins

Dalriada Drug Discovery and Topos Bio collaborate to accelerate drug discovery for intrinsically disordered proteins using AI, mass spectrometry and proteomics to improve experimental validation and therapeutic development.

Research Collaboration | 18/03/2026 | By News Bureau 161

Samsung Bioepis and Epis NexLab Partner G2GBIO to Develop Long-Acting Semaglutide

Samsung Bioepis and Epis NexLab Partner G2GBIO to Develop Long-Acting Semaglutide

Samsung Bioepis and Epis NexLab have signed a research collaboration and licensing agreement with G2GBIO to develop novel assets, including long-acting semaglutide, using G2GBIO’s proprietary microsphere drug delivery technology.

Research Collaboration | 16/03/2026 | By News Bureau 120

Variant Bio partners with Boehringer Ingelheim for Research on Kidney Disease

Variant Bio partners with Boehringer Ingelheim for Research on Kidney Disease

The multi-year collaboration with Boehringer Ingelheim will leverage Variant Bio’s AI-powered Inference platform to identify novel kidney disease drug targets, with financial terms including upfront, licence and milestone payments that could exceed USD 120 million.

Research Collaboration | 08/01/2026 | By News Bureau 217

Ipsen and Skyhawk Therapeutics to Work on RNA Targeting Research in Rare Neurological Diseases

Ipsen and Skyhawk Therapeutics to Work on RNA Targeting Research in Rare Neurological Diseases

Ipsen has signed an exclusive worldwide collaboration with Skyhawk Therapeutics to discover and develop novel small molecules that modulate RNA for rare neurological diseases.

Research Collaboration | 22/04/2024 | By Aishwarya 512


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members